Close Menu

NEW YORK (GenomeWeb) – Caprion Biosciences said today it has acquired biomarker and immune monitoring firm Primity Bio.

According to Caprion, the company plans to use Primity's assets to expand its existing immunology and molecular profiling business.

Financial and other terms of the deal were not disclosed

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.